Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Supply, Demand and Key Producers, 2026-2032
The global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market size is expected to reach $ 18278 million by 2032, rising at a market growth of 20.4% CAGR during the forecast period (2026-2032).
Non-steroidal androgen receptor inhibitors (NSARIs) are a class of oral small-molecule drugs that competitively bind to the androgen receptor (AR), inhibiting its nuclear translocation and transcriptional activity without possessing a steroidal structure; they selectively block androgen signaling pathways that drive prostate cancer progression and represent a core component of endocrine therapy for prostate cancer; the class has evolved from first-generation agents (e.g., bicalutamide) to second-generation high-affinity inhibitors such as Enzalutamide, Apalutamide, and Darolutamide, with continuous improvements in efficacy, resistance management, and safety profile, primarily indicated for nmCRPC and mHSPC and typically used in combination with androgen deprivation therapy (ADT).The global market for non-steroidal androgen receptor inhibitors is estimated at USD 4.8 billion in 2025, with a projected CAGR of approximately 20.85% from 2025 to 2030, corresponding to an annual treated patient population of about 500,000–600,000, driven by increasing penetration in nmCRPC, mCRPC, and mHSPC. Nominal capacity from the global high-potency small-molecule API network is sufficient to meet demand, and capacity does not constitute a constraint. Average treatment cost per patient per year is approximately USD 90,000–100,000 in the U.S., USD 50,000–70,000 in Europe, and USD 15,000–20,000 in China post-reimbursement negotiations, resulting in a weighted average of about USD 65,000 per patient per year, with a blended gross margin of roughly 85–90%.
Downstream demand is concentrated in the prostate cancer treatment pathway within oncology (nmCRPC ? mCRPC ? mHSPC). The value chain upstream consists of high-potency APIs and key intermediates synthesized via multi-step heterocyclic processes; midstream commercialization is led by originator companies (Astellas Pharma Inc., Pfizer Inc., Johnson & Johnson, and Bayer AG/Orion Corporation); downstream channels consist of hospitals and oncology specialty clinics. The global industry structure is characterized by “originator oligopoly + guideline-driven adoption + patent protection,” with primary competition from Enzalutamide, Apalutamide, and Darolutamide. The core compound patent of Darolutamide is expected to expire around 2030, but indication, formulation, and regional patent extensions may prolong actual market exclusivity to 2032–2035. Overall, the market is in the late growth stage, driven primarily by indication expansion and an increasing aging patient population, with key uncertainty arising from post-patent generic entry and reimbursement pressure.
This report studies the global Non-steroidal Androgen Receptor Inhibitors?NSARIs? production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Non-steroidal Androgen Receptor Inhibitors?NSARIs? and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-steroidal Androgen Receptor Inhibitors?NSARIs? that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? total production and demand, 2021-2032, (Tons)
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? total production value, 2021-2032, (USD Million)
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Tons), (based on production site)
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? consumption by region & country, CAGR, 2021-2032 & (Tons)
U.S. VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? domestic production, consumption, key domestic manufacturers and share
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Tons)
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
This report profiles key players in the global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Astellas Pharma, Pfizer, Johnson & Johnson, Bayer AG, Orion, Lonza Group, Catalent, WuXi AppTec, Asymchem Laboratories, Recipharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Non-steroidal Androgen Receptor Inhibitors?NSARIs? market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market, By Region:
1. How big is the global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market?
2. What is the demand of the global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market?
3. What is the year over year growth of the global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market?
4. What is the production and production value of the global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market?
5. Who are the key producers in the global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market?
6. What are the growth factors driving the market demand?
Non-steroidal androgen receptor inhibitors (NSARIs) are a class of oral small-molecule drugs that competitively bind to the androgen receptor (AR), inhibiting its nuclear translocation and transcriptional activity without possessing a steroidal structure; they selectively block androgen signaling pathways that drive prostate cancer progression and represent a core component of endocrine therapy for prostate cancer; the class has evolved from first-generation agents (e.g., bicalutamide) to second-generation high-affinity inhibitors such as Enzalutamide, Apalutamide, and Darolutamide, with continuous improvements in efficacy, resistance management, and safety profile, primarily indicated for nmCRPC and mHSPC and typically used in combination with androgen deprivation therapy (ADT).The global market for non-steroidal androgen receptor inhibitors is estimated at USD 4.8 billion in 2025, with a projected CAGR of approximately 20.85% from 2025 to 2030, corresponding to an annual treated patient population of about 500,000–600,000, driven by increasing penetration in nmCRPC, mCRPC, and mHSPC. Nominal capacity from the global high-potency small-molecule API network is sufficient to meet demand, and capacity does not constitute a constraint. Average treatment cost per patient per year is approximately USD 90,000–100,000 in the U.S., USD 50,000–70,000 in Europe, and USD 15,000–20,000 in China post-reimbursement negotiations, resulting in a weighted average of about USD 65,000 per patient per year, with a blended gross margin of roughly 85–90%.
Downstream demand is concentrated in the prostate cancer treatment pathway within oncology (nmCRPC ? mCRPC ? mHSPC). The value chain upstream consists of high-potency APIs and key intermediates synthesized via multi-step heterocyclic processes; midstream commercialization is led by originator companies (Astellas Pharma Inc., Pfizer Inc., Johnson & Johnson, and Bayer AG/Orion Corporation); downstream channels consist of hospitals and oncology specialty clinics. The global industry structure is characterized by “originator oligopoly + guideline-driven adoption + patent protection,” with primary competition from Enzalutamide, Apalutamide, and Darolutamide. The core compound patent of Darolutamide is expected to expire around 2030, but indication, formulation, and regional patent extensions may prolong actual market exclusivity to 2032–2035. Overall, the market is in the late growth stage, driven primarily by indication expansion and an increasing aging patient population, with key uncertainty arising from post-patent generic entry and reimbursement pressure.
This report studies the global Non-steroidal Androgen Receptor Inhibitors?NSARIs? production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Non-steroidal Androgen Receptor Inhibitors?NSARIs? and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-steroidal Androgen Receptor Inhibitors?NSARIs? that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? total production and demand, 2021-2032, (Tons)
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? total production value, 2021-2032, (USD Million)
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Tons), (based on production site)
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? consumption by region & country, CAGR, 2021-2032 & (Tons)
U.S. VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? domestic production, consumption, key domestic manufacturers and share
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Tons)
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
This report profiles key players in the global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Astellas Pharma, Pfizer, Johnson & Johnson, Bayer AG, Orion, Lonza Group, Catalent, WuXi AppTec, Asymchem Laboratories, Recipharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Non-steroidal Androgen Receptor Inhibitors?NSARIs? market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Enzalutamide
- Apalutamide
- Darolutamide
- Bicalutamide
- Nilutamide
- High BBB Penetration
- Low BBB Penetration
- nmCRPC
- mCRPC
- mHSPC
- Others
- Astellas Pharma
- Pfizer
- Johnson & Johnson
- Bayer AG
- Orion
- Lonza Group
- Catalent
- WuXi AppTec
- Asymchem Laboratories
- Recipharm
1. How big is the global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market?
2. What is the demand of the global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market?
3. What is the year over year growth of the global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market?
4. What is the production and production value of the global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market?
5. Who are the key producers in the global Non-steroidal Androgen Receptor Inhibitors?NSARIs? market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Introduction
1.2 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Supply & Forecast
1.2.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value (2021 & 2025 & 2032)
1.2.2 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2032)
1.2.3 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Pricing Trends (2021-2032)
1.3 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Region (Based on Production Site)
1.3.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Region (2021-2032)
1.3.2 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Region (2021-2032)
1.3.3 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Region (2021-2032)
1.3.4 North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2032)
1.3.5 Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2032)
1.3.6 China Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2032)
1.3.7 Japan Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Major Market Trends
2 DEMAND SUMMARY
2.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Demand (2021-2032)
2.2 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption by Region
2.2.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption by Region (2021-2026)
2.2.2 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Forecast by Region (2027-2032)
2.3 United States Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032)
2.4 China Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032)
2.5 Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032)
2.6 Japan Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032)
2.7 South Korea Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032)
2.8 ASEAN Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032)
2.9 India Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Manufacturer (2021-2026)
3.2 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Manufacturer (2021-2026)
3.3 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Manufacturer (2021-2026)
3.4 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Non-steroidal Androgen Receptor Inhibitors?NSARIs? in 2025
3.5.3 Global Concentration Ratios (CR8) for Non-steroidal Androgen Receptor Inhibitors?NSARIs? in 2025
3.6 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Overall Company Footprint Analysis
3.6.1 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Region Footprint
3.6.2 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Company Product Type Footprint
3.6.3 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Comparison
4.1.1 United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Comparison
4.2.1 United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Comparison
4.3.1 United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value (2021-2026)
4.4.3 United States Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2026)
4.5 China Based Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturers and Market Share
4.5.1 China Based Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value (2021-2026)
4.5.3 China Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2026)
4.6 Rest of World Based Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Enzalutamide
5.2.2 Apalutamide
5.2.3 Darolutamide
5.2.4 Bicalutamide
5.2.5 Nilutamide
5.3 Market Segment by Type
5.3.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Type (2021-2032)
5.3.2 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Type (2021-2032)
5.3.3 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY MOLECULAR
6.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Size Overview by Molecular: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Molecular
6.2.1 High BBB Penetration
6.2.2 Low BBB Penetration
6.3 Market Segment by Molecular
6.3.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Molecular (2021-2032)
6.3.2 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Molecular (2021-2032)
6.3.3 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Molecular (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 nmCRPC
7.2.2 mCRPC
7.2.3 mHSPC
7.2.4 Others
7.3 Market Segment by Application
7.3.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Application (2021-2032)
7.3.2 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Application (2021-2032)
7.3.3 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Astellas Pharma
8.1.1 Astellas Pharma Details
8.1.2 Astellas Pharma Major Business
8.1.3 Astellas Pharma Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
8.1.4 Astellas Pharma Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Astellas Pharma Recent Developments/Updates
8.1.6 Astellas Pharma Competitive Strengths & Weaknesses
8.2 Pfizer
8.2.1 Pfizer Details
8.2.2 Pfizer Major Business
8.2.3 Pfizer Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
8.2.4 Pfizer Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 Pfizer Recent Developments/Updates
8.2.6 Pfizer Competitive Strengths & Weaknesses
8.3 Johnson & Johnson
8.3.1 Johnson & Johnson Details
8.3.2 Johnson & Johnson Major Business
8.3.3 Johnson & Johnson Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
8.3.4 Johnson & Johnson Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Johnson & Johnson Recent Developments/Updates
8.3.6 Johnson & Johnson Competitive Strengths & Weaknesses
8.4 Bayer AG
8.4.1 Bayer AG Details
8.4.2 Bayer AG Major Business
8.4.3 Bayer AG Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
8.4.4 Bayer AG Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Bayer AG Recent Developments/Updates
8.4.6 Bayer AG Competitive Strengths & Weaknesses
8.5 Orion
8.5.1 Orion Details
8.5.2 Orion Major Business
8.5.3 Orion Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
8.5.4 Orion Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Orion Recent Developments/Updates
8.5.6 Orion Competitive Strengths & Weaknesses
8.6 Lonza Group
8.6.1 Lonza Group Details
8.6.2 Lonza Group Major Business
8.6.3 Lonza Group Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
8.6.4 Lonza Group Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 Lonza Group Recent Developments/Updates
8.6.6 Lonza Group Competitive Strengths & Weaknesses
8.7 Catalent
8.7.1 Catalent Details
8.7.2 Catalent Major Business
8.7.3 Catalent Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
8.7.4 Catalent Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Catalent Recent Developments/Updates
8.7.6 Catalent Competitive Strengths & Weaknesses
8.8 WuXi AppTec
8.8.1 WuXi AppTec Details
8.8.2 WuXi AppTec Major Business
8.8.3 WuXi AppTec Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
8.8.4 WuXi AppTec Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 WuXi AppTec Recent Developments/Updates
8.8.6 WuXi AppTec Competitive Strengths & Weaknesses
8.9 Asymchem Laboratories
8.9.1 Asymchem Laboratories Details
8.9.2 Asymchem Laboratories Major Business
8.9.3 Asymchem Laboratories Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
8.9.4 Asymchem Laboratories Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 Asymchem Laboratories Recent Developments/Updates
8.9.6 Asymchem Laboratories Competitive Strengths & Weaknesses
8.10 Recipharm
8.10.1 Recipharm Details
8.10.2 Recipharm Major Business
8.10.3 Recipharm Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
8.10.4 Recipharm Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.10.5 Recipharm Recent Developments/Updates
8.10.6 Recipharm Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Industry Chain
9.2 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Upstream Analysis
9.2.1 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Core Raw Materials
9.2.2 Main Manufacturers of Non-steroidal Androgen Receptor Inhibitors?NSARIs? Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Mode
9.6 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Procurement Model
9.7 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Industry Sales Model and Sales Channels
9.7.1 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Model
9.7.2 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Introduction
1.2 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Supply & Forecast
1.2.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value (2021 & 2025 & 2032)
1.2.2 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2032)
1.2.3 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Pricing Trends (2021-2032)
1.3 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Region (Based on Production Site)
1.3.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Region (2021-2032)
1.3.2 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Region (2021-2032)
1.3.3 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Region (2021-2032)
1.3.4 North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2032)
1.3.5 Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2032)
1.3.6 China Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2032)
1.3.7 Japan Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Major Market Trends
2 DEMAND SUMMARY
2.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Demand (2021-2032)
2.2 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption by Region
2.2.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption by Region (2021-2026)
2.2.2 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Forecast by Region (2027-2032)
2.3 United States Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032)
2.4 China Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032)
2.5 Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032)
2.6 Japan Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032)
2.7 South Korea Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032)
2.8 ASEAN Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032)
2.9 India Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Manufacturer (2021-2026)
3.2 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Manufacturer (2021-2026)
3.3 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Manufacturer (2021-2026)
3.4 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Non-steroidal Androgen Receptor Inhibitors?NSARIs? in 2025
3.5.3 Global Concentration Ratios (CR8) for Non-steroidal Androgen Receptor Inhibitors?NSARIs? in 2025
3.6 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Overall Company Footprint Analysis
3.6.1 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Region Footprint
3.6.2 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Company Product Type Footprint
3.6.3 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Comparison
4.1.1 United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Comparison
4.2.1 United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Comparison
4.3.1 United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value (2021-2026)
4.4.3 United States Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2026)
4.5 China Based Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturers and Market Share
4.5.1 China Based Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value (2021-2026)
4.5.3 China Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2026)
4.6 Rest of World Based Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Enzalutamide
5.2.2 Apalutamide
5.2.3 Darolutamide
5.2.4 Bicalutamide
5.2.5 Nilutamide
5.3 Market Segment by Type
5.3.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Type (2021-2032)
5.3.2 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Type (2021-2032)
5.3.3 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY MOLECULAR
6.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Size Overview by Molecular: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Molecular
6.2.1 High BBB Penetration
6.2.2 Low BBB Penetration
6.3 Market Segment by Molecular
6.3.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Molecular (2021-2032)
6.3.2 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Molecular (2021-2032)
6.3.3 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Molecular (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 nmCRPC
7.2.2 mCRPC
7.2.3 mHSPC
7.2.4 Others
7.3 Market Segment by Application
7.3.1 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Application (2021-2032)
7.3.2 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Application (2021-2032)
7.3.3 World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Astellas Pharma
8.1.1 Astellas Pharma Details
8.1.2 Astellas Pharma Major Business
8.1.3 Astellas Pharma Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
8.1.4 Astellas Pharma Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Astellas Pharma Recent Developments/Updates
8.1.6 Astellas Pharma Competitive Strengths & Weaknesses
8.2 Pfizer
8.2.1 Pfizer Details
8.2.2 Pfizer Major Business
8.2.3 Pfizer Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
8.2.4 Pfizer Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 Pfizer Recent Developments/Updates
8.2.6 Pfizer Competitive Strengths & Weaknesses
8.3 Johnson & Johnson
8.3.1 Johnson & Johnson Details
8.3.2 Johnson & Johnson Major Business
8.3.3 Johnson & Johnson Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
8.3.4 Johnson & Johnson Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Johnson & Johnson Recent Developments/Updates
8.3.6 Johnson & Johnson Competitive Strengths & Weaknesses
8.4 Bayer AG
8.4.1 Bayer AG Details
8.4.2 Bayer AG Major Business
8.4.3 Bayer AG Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
8.4.4 Bayer AG Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Bayer AG Recent Developments/Updates
8.4.6 Bayer AG Competitive Strengths & Weaknesses
8.5 Orion
8.5.1 Orion Details
8.5.2 Orion Major Business
8.5.3 Orion Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
8.5.4 Orion Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.5.5 Orion Recent Developments/Updates
8.5.6 Orion Competitive Strengths & Weaknesses
8.6 Lonza Group
8.6.1 Lonza Group Details
8.6.2 Lonza Group Major Business
8.6.3 Lonza Group Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
8.6.4 Lonza Group Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.6.5 Lonza Group Recent Developments/Updates
8.6.6 Lonza Group Competitive Strengths & Weaknesses
8.7 Catalent
8.7.1 Catalent Details
8.7.2 Catalent Major Business
8.7.3 Catalent Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
8.7.4 Catalent Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.7.5 Catalent Recent Developments/Updates
8.7.6 Catalent Competitive Strengths & Weaknesses
8.8 WuXi AppTec
8.8.1 WuXi AppTec Details
8.8.2 WuXi AppTec Major Business
8.8.3 WuXi AppTec Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
8.8.4 WuXi AppTec Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.8.5 WuXi AppTec Recent Developments/Updates
8.8.6 WuXi AppTec Competitive Strengths & Weaknesses
8.9 Asymchem Laboratories
8.9.1 Asymchem Laboratories Details
8.9.2 Asymchem Laboratories Major Business
8.9.3 Asymchem Laboratories Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
8.9.4 Asymchem Laboratories Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.9.5 Asymchem Laboratories Recent Developments/Updates
8.9.6 Asymchem Laboratories Competitive Strengths & Weaknesses
8.10 Recipharm
8.10.1 Recipharm Details
8.10.2 Recipharm Major Business
8.10.3 Recipharm Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
8.10.4 Recipharm Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.10.5 Recipharm Recent Developments/Updates
8.10.6 Recipharm Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Industry Chain
9.2 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Upstream Analysis
9.2.1 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Core Raw Materials
9.2.2 Main Manufacturers of Non-steroidal Androgen Receptor Inhibitors?NSARIs? Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Mode
9.6 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Procurement Model
9.7 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Industry Sales Model and Sales Channels
9.7.1 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Model
9.7.2 Non-steroidal Androgen Receptor Inhibitors?NSARIs? Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Region (2021-2026) & (USD Million)
Table 3. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Region (2027-2032) & (USD Million)
Table 4. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share by Region (2021-2026)
Table 5. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share by Region (2027-2032)
Table 6. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Region (2021-2026) & (Tons)
Table 7. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Region (2027-2032) & (Tons)
Table 8. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share by Region (2021-2026)
Table 9. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share by Region (2027-2032)
Table 10. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Region (2021-2026) & (US$/Ton)
Table 11. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Region (2027-2032) & (US$/Ton)
Table 12. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Major Market Trends
Table 13. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Tons)
Table 14. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption by Region (2021-2026) & (Tons)
Table 15. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Forecast by Region (2027-2032) & (Tons)
Table 16. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Non-steroidal Androgen Receptor Inhibitors?NSARIs? Producers in 2025
Table 18. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Manufacturer (2021-2026) & (Tons)
Table 19. Production Market Share of Key Non-steroidal Androgen Receptor Inhibitors?NSARIs? Producers in 2025
Table 20. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Manufacturer (2021-2026) & (US$/Ton)
Table 21. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Company Evaluation Quadrant
Table 22. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Site of Key Manufacturer
Table 24. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Company Product Type Footprint
Table 25. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Company Product Application Footprint
Table 26. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Competitive Factors
Table 27. Non-steroidal Androgen Receptor Inhibitors?NSARIs? New Entrant and Capacity Expansion Plans
Table 28. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Mergers & Acquisitions Activity
Table 29. United States VS China Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Comparison, (2021 & 2025 & 2032) & (Tons)
Table 31. United States VS China Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Comparison, (2021 & 2025 & 2032) & (Tons)
Table 32. United States Based Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2026) & (Tons)
Table 36. United States Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share (2021-2026)
Table 37. China Based Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, (2021-2026) & (Tons)
Table 41. China Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share (2021-2026)
Table 42. Rest of World Based Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, (2021-2026) & (Tons)
Table 46. Rest of World Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share (2021-2026)
Table 47. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Type (2021-2026) & (Tons)
Table 49. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Type (2027-2032) & (Tons)
Table 50. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Type (2021-2026) & (USD Million)
Table 51. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Type (2027-2032) & (USD Million)
Table 52. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Type (2021-2026) & (US$/Ton)
Table 53. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Type (2027-2032) & (US$/Ton)
Table 54. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Molecular, (USD Million), 2021 & 2025 & 2032
Table 55. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Molecular (2021-2026) & (Tons)
Table 56. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Molecular (2027-2032) & (Tons)
Table 57. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Molecular (2021-2026) & (USD Million)
Table 58. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Molecular (2027-2032) & (USD Million)
Table 59. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Molecular (2021-2026) & (US$/Ton)
Table 60. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Molecular (2027-2032) & (US$/Ton)
Table 61. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Application (2021-2026) & (Tons)
Table 63. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Application (2027-2032) & (Tons)
Table 64. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Application (2021-2026) & (USD Million)
Table 65. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Application (2027-2032) & (USD Million)
Table 66. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Application (2021-2026) & (US$/Ton)
Table 67. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Application (2027-2032) & (US$/Ton)
Table 68. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 69. Astellas Pharma Major Business
Table 70. Astellas Pharma Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 71. Astellas Pharma Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Astellas Pharma Recent Developments/Updates
Table 73. Astellas Pharma Competitive Strengths & Weaknesses
Table 74. Pfizer Basic Information, Manufacturing Base and Competitors
Table 75. Pfizer Major Business
Table 76. Pfizer Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 77. Pfizer Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Pfizer Recent Developments/Updates
Table 79. Pfizer Competitive Strengths & Weaknesses
Table 80. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 81. Johnson & Johnson Major Business
Table 82. Johnson & Johnson Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 83. Johnson & Johnson Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. Johnson & Johnson Competitive Strengths & Weaknesses
Table 86. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 87. Bayer AG Major Business
Table 88. Bayer AG Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 89. Bayer AG Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Bayer AG Recent Developments/Updates
Table 91. Bayer AG Competitive Strengths & Weaknesses
Table 92. Orion Basic Information, Manufacturing Base and Competitors
Table 93. Orion Major Business
Table 94. Orion Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 95. Orion Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Orion Recent Developments/Updates
Table 97. Orion Competitive Strengths & Weaknesses
Table 98. Lonza Group Basic Information, Manufacturing Base and Competitors
Table 99. Lonza Group Major Business
Table 100. Lonza Group Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 101. Lonza Group Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. Lonza Group Recent Developments/Updates
Table 103. Lonza Group Competitive Strengths & Weaknesses
Table 104. Catalent Basic Information, Manufacturing Base and Competitors
Table 105. Catalent Major Business
Table 106. Catalent Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 107. Catalent Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Catalent Recent Developments/Updates
Table 109. Catalent Competitive Strengths & Weaknesses
Table 110. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 111. WuXi AppTec Major Business
Table 112. WuXi AppTec Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 113. WuXi AppTec Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. WuXi AppTec Recent Developments/Updates
Table 115. WuXi AppTec Competitive Strengths & Weaknesses
Table 116. Asymchem Laboratories Basic Information, Manufacturing Base and Competitors
Table 117. Asymchem Laboratories Major Business
Table 118. Asymchem Laboratories Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 119. Asymchem Laboratories Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Asymchem Laboratories Recent Developments/Updates
Table 121. Asymchem Laboratories Competitive Strengths & Weaknesses
Table 122. Recipharm Basic Information, Manufacturing Base and Competitors
Table 123. Recipharm Major Business
Table 124. Recipharm Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 125. Recipharm Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. Recipharm Recent Developments/Updates
Table 127. Recipharm Competitive Strengths & Weaknesses
Table 128. Global Key Players of Non-steroidal Androgen Receptor Inhibitors?NSARIs? Upstream (Raw Materials)
Table 129. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Typical Customers
Table 130. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Typical Distributors
Table 1. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Region (2021-2026) & (USD Million)
Table 3. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Region (2027-2032) & (USD Million)
Table 4. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share by Region (2021-2026)
Table 5. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share by Region (2027-2032)
Table 6. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Region (2021-2026) & (Tons)
Table 7. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Region (2027-2032) & (Tons)
Table 8. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share by Region (2021-2026)
Table 9. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share by Region (2027-2032)
Table 10. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Region (2021-2026) & (US$/Ton)
Table 11. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Region (2027-2032) & (US$/Ton)
Table 12. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Major Market Trends
Table 13. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Tons)
Table 14. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption by Region (2021-2026) & (Tons)
Table 15. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Forecast by Region (2027-2032) & (Tons)
Table 16. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Non-steroidal Androgen Receptor Inhibitors?NSARIs? Producers in 2025
Table 18. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Manufacturer (2021-2026) & (Tons)
Table 19. Production Market Share of Key Non-steroidal Androgen Receptor Inhibitors?NSARIs? Producers in 2025
Table 20. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Manufacturer (2021-2026) & (US$/Ton)
Table 21. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Company Evaluation Quadrant
Table 22. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Site of Key Manufacturer
Table 24. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Company Product Type Footprint
Table 25. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market: Company Product Application Footprint
Table 26. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Competitive Factors
Table 27. Non-steroidal Androgen Receptor Inhibitors?NSARIs? New Entrant and Capacity Expansion Plans
Table 28. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Mergers & Acquisitions Activity
Table 29. United States VS China Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Comparison, (2021 & 2025 & 2032) & (Tons)
Table 31. United States VS China Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Comparison, (2021 & 2025 & 2032) & (Tons)
Table 32. United States Based Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2026) & (Tons)
Table 36. United States Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share (2021-2026)
Table 37. China Based Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, (2021-2026) & (Tons)
Table 41. China Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share (2021-2026)
Table 42. Rest of World Based Non-steroidal Androgen Receptor Inhibitors?NSARIs? Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production, (2021-2026) & (Tons)
Table 46. Rest of World Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share (2021-2026)
Table 47. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Type (2021-2026) & (Tons)
Table 49. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Type (2027-2032) & (Tons)
Table 50. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Type (2021-2026) & (USD Million)
Table 51. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Type (2027-2032) & (USD Million)
Table 52. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Type (2021-2026) & (US$/Ton)
Table 53. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Type (2027-2032) & (US$/Ton)
Table 54. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Molecular, (USD Million), 2021 & 2025 & 2032
Table 55. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Molecular (2021-2026) & (Tons)
Table 56. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Molecular (2027-2032) & (Tons)
Table 57. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Molecular (2021-2026) & (USD Million)
Table 58. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Molecular (2027-2032) & (USD Million)
Table 59. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Molecular (2021-2026) & (US$/Ton)
Table 60. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Molecular (2027-2032) & (US$/Ton)
Table 61. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Application (2021-2026) & (Tons)
Table 63. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production by Application (2027-2032) & (Tons)
Table 64. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Application (2021-2026) & (USD Million)
Table 65. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Application (2027-2032) & (USD Million)
Table 66. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Application (2021-2026) & (US$/Ton)
Table 67. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Application (2027-2032) & (US$/Ton)
Table 68. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 69. Astellas Pharma Major Business
Table 70. Astellas Pharma Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 71. Astellas Pharma Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Astellas Pharma Recent Developments/Updates
Table 73. Astellas Pharma Competitive Strengths & Weaknesses
Table 74. Pfizer Basic Information, Manufacturing Base and Competitors
Table 75. Pfizer Major Business
Table 76. Pfizer Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 77. Pfizer Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Pfizer Recent Developments/Updates
Table 79. Pfizer Competitive Strengths & Weaknesses
Table 80. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 81. Johnson & Johnson Major Business
Table 82. Johnson & Johnson Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 83. Johnson & Johnson Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. Johnson & Johnson Competitive Strengths & Weaknesses
Table 86. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 87. Bayer AG Major Business
Table 88. Bayer AG Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 89. Bayer AG Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Bayer AG Recent Developments/Updates
Table 91. Bayer AG Competitive Strengths & Weaknesses
Table 92. Orion Basic Information, Manufacturing Base and Competitors
Table 93. Orion Major Business
Table 94. Orion Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 95. Orion Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 96. Orion Recent Developments/Updates
Table 97. Orion Competitive Strengths & Weaknesses
Table 98. Lonza Group Basic Information, Manufacturing Base and Competitors
Table 99. Lonza Group Major Business
Table 100. Lonza Group Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 101. Lonza Group Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 102. Lonza Group Recent Developments/Updates
Table 103. Lonza Group Competitive Strengths & Weaknesses
Table 104. Catalent Basic Information, Manufacturing Base and Competitors
Table 105. Catalent Major Business
Table 106. Catalent Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 107. Catalent Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 108. Catalent Recent Developments/Updates
Table 109. Catalent Competitive Strengths & Weaknesses
Table 110. WuXi AppTec Basic Information, Manufacturing Base and Competitors
Table 111. WuXi AppTec Major Business
Table 112. WuXi AppTec Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 113. WuXi AppTec Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. WuXi AppTec Recent Developments/Updates
Table 115. WuXi AppTec Competitive Strengths & Weaknesses
Table 116. Asymchem Laboratories Basic Information, Manufacturing Base and Competitors
Table 117. Asymchem Laboratories Major Business
Table 118. Asymchem Laboratories Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 119. Asymchem Laboratories Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Asymchem Laboratories Recent Developments/Updates
Table 121. Asymchem Laboratories Competitive Strengths & Weaknesses
Table 122. Recipharm Basic Information, Manufacturing Base and Competitors
Table 123. Recipharm Major Business
Table 124. Recipharm Non-steroidal Androgen Receptor Inhibitors?NSARIs? Product and Services
Table 125. Recipharm Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 126. Recipharm Recent Developments/Updates
Table 127. Recipharm Competitive Strengths & Weaknesses
Table 128. Global Key Players of Non-steroidal Androgen Receptor Inhibitors?NSARIs? Upstream (Raw Materials)
Table 129. Global Non-steroidal Androgen Receptor Inhibitors?NSARIs? Typical Customers
Table 130. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Typical Distributors
LIST OF FIGURES
Figure 1. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Picture
Figure 2. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2032) & (Tons)
Figure 5. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price (2021-2032) & (US$/Ton)
Figure 6. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share by Region (2021-2032)
Figure 7. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share by Region (2021-2032)
Figure 8. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2032) & (Tons)
Figure 9. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2032) & (Tons)
Figure 10. China Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2032) & (Tons)
Figure 11. Japan Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2032) & (Tons)
Figure 12. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032) & (Tons)
Figure 15. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Market Share by Region (2021-2032)
Figure 16. United States Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032) & (Tons)
Figure 17. China Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032) & (Tons)
Figure 18. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032) & (Tons)
Figure 19. Japan Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032) & (Tons)
Figure 20. South Korea Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032) & (Tons)
Figure 21. ASEAN Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032) & (Tons)
Figure 22. India Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032) & (Tons)
Figure 23. Producer Shipments of Non-steroidal Androgen Receptor Inhibitors?NSARIs? by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Non-steroidal Androgen Receptor Inhibitors?NSARIs? Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Non-steroidal Androgen Receptor Inhibitors?NSARIs? Markets in 2025
Figure 26. United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share 2025
Figure 30. China Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share 2025
Figure 32. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share by Type in 2025
Figure 34. Enzalutamide
Figure 35. Apalutamide
Figure 36. Darolutamide
Figure 37. Bicalutamide
Figure 38. Nilutamide
Figure 39. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share by Type (2021-2032)
Figure 40. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share by Type (2021-2032)
Figure 41. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Type (2021-2032) & (US$/Ton)
Figure 42. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Molecular, (USD Million), 2021 & 2025 & 2032
Figure 43. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share by Molecular in 2025
Figure 44. High BBB Penetration
Figure 45. Low BBB Penetration
Figure 46. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share by Molecular (2021-2032)
Figure 47. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share by Molecular (2021-2032)
Figure 48. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Molecular (2021-2032) & (US$/Ton)
Figure 49. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share by Application in 2025
Figure 51. nmCRPC
Figure 52. mCRPC
Figure 53. mHSPC
Figure 54. Others
Figure 55. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share by Application (2021-2032)
Figure 56. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share by Application (2021-2032)
Figure 57. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Application (2021-2032) & (US$/Ton)
Figure 58. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Industry Chain
Figure 59. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Procurement Model
Figure 60. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Model
Figure 61. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Channels, Direct Sales, and Distribution
Figure 62. Methodology
Figure 63. Research Process and Data Source
Figure 1. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Picture
Figure 2. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2032) & (Tons)
Figure 5. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price (2021-2032) & (US$/Ton)
Figure 6. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share by Region (2021-2032)
Figure 7. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share by Region (2021-2032)
Figure 8. North America Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2032) & (Tons)
Figure 9. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2032) & (Tons)
Figure 10. China Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2032) & (Tons)
Figure 11. Japan Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production (2021-2032) & (Tons)
Figure 12. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032) & (Tons)
Figure 15. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Market Share by Region (2021-2032)
Figure 16. United States Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032) & (Tons)
Figure 17. China Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032) & (Tons)
Figure 18. Europe Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032) & (Tons)
Figure 19. Japan Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032) & (Tons)
Figure 20. South Korea Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032) & (Tons)
Figure 21. ASEAN Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032) & (Tons)
Figure 22. India Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption (2021-2032) & (Tons)
Figure 23. Producer Shipments of Non-steroidal Androgen Receptor Inhibitors?NSARIs? by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Non-steroidal Androgen Receptor Inhibitors?NSARIs? Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Non-steroidal Androgen Receptor Inhibitors?NSARIs? Markets in 2025
Figure 26. United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Non-steroidal Androgen Receptor Inhibitors?NSARIs? Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share 2025
Figure 30. China Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share 2025
Figure 32. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share by Type in 2025
Figure 34. Enzalutamide
Figure 35. Apalutamide
Figure 36. Darolutamide
Figure 37. Bicalutamide
Figure 38. Nilutamide
Figure 39. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share by Type (2021-2032)
Figure 40. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share by Type (2021-2032)
Figure 41. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Type (2021-2032) & (US$/Ton)
Figure 42. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Molecular, (USD Million), 2021 & 2025 & 2032
Figure 43. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share by Molecular in 2025
Figure 44. High BBB Penetration
Figure 45. Low BBB Penetration
Figure 46. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share by Molecular (2021-2032)
Figure 47. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share by Molecular (2021-2032)
Figure 48. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Molecular (2021-2032) & (US$/Ton)
Figure 49. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share by Application in 2025
Figure 51. nmCRPC
Figure 52. mCRPC
Figure 53. mHSPC
Figure 54. Others
Figure 55. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Market Share by Application (2021-2032)
Figure 56. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Production Value Market Share by Application (2021-2032)
Figure 57. World Non-steroidal Androgen Receptor Inhibitors?NSARIs? Average Price by Application (2021-2032) & (US$/Ton)
Figure 58. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Industry Chain
Figure 59. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Procurement Model
Figure 60. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Model
Figure 61. Non-steroidal Androgen Receptor Inhibitors?NSARIs? Sales Channels, Direct Sales, and Distribution
Figure 62. Methodology
Figure 63. Research Process and Data Source
